Axonics Expands Sacral Neuromodulation Intellectual Property Portfolio
Axonics, Inc. (NASDAQ:AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced that in the last twelve months,